Cardlytics (CDLX)
(Delayed Data from NSDQ)
$1.76 USD
-0.08 (-4.35%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.39 -0.37 (-21.02%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Cardlytics, Inc. has a market cap of $96.60M, which represents its share price of $1.84 multiplied by its outstanding shares number of 52.50M. As a small-cap company, CDLX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CDLX 1.76 -0.08(-4.35%)
Will CDLX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CDLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDLX
Cardlytics (CDLX) Reports Q2 Loss, Misses Revenue Estimates
Blade Air Mobility, Inc. (BLDE) Reports Q2 Loss, Tops Revenue Estimates
CDLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cardlytics (CDLX) Shows Fast-paced Momentum But Is Still a Bargain Stock
Cardlytics (CDLX) Reports Q1 Loss, Tops Revenue Estimates
Priority Technology (PRTH) Surpasses Q1 Earnings Estimates
Other News for CDLX
Q2 2025 Cardlytics Inc Earnings Call Transcript
Cardlytics signals up to $95M Q3 billings amid major FI partner content restrictions
Cardlytics, Inc. (CDLX) Q2 2025 Earnings Call Transcript
Cardlytics Non-GAAP EPS of -$0.13 beats by $0.03, revenue of $63.2M misses by $0.82M
Cardlytics sees Q3 revenue $52.2M-$58.2M, consensus $67.33M